High risk in atrial fibrillation following an ablation procedure: the wide usefulness of the CHADS(2) score.

Future Cardiol

Service de Cardiologie B et Laboratoire d'Electrophysiologie Cardiaque, Pole Cœur Thorax Vasculaire, Centre Hospitalier Universitaire Trousseau, 37044 Tours, France.

Published: September 2012

AI Article Synopsis

  • The study analyzed data from 238 patients with paroxysmal atrial fibrillation (AF) who underwent catheter ablation, finding that a higher CHADS(2) score is associated with increased risk of AF recurrences post-procedure.
  • It reported that patients with a CHADS(2) score under three had a 64% recurrence rate after two years, while those with a score of zero had only a 3% recurrence rate, suggesting that the score reflects the severity of underlying conditions.
  • The authors highlighted the need for further investigation to determine if using the simpler CHADS(2) score is effective for assessing overall risk of future AF-related events compared to more complex scoring systems.

Article Abstract

Evaluation of: Chao TF, Ambrose K, Tsao HM et al. Relationship between the CHADS(2) score and risk of very late recurrences after catheter ablation of paroxysmal atrial fibrillation. Heart Rhythm 9(8), 1185-1191 (2012). Limited data are available on the predictors of adverse events and recurrences in patients with atrial fibrillation (AF) after catheter ablation. In a retrospective analysis of 238 patients with paroxysmal AF treated with catheter ablation, it was found that the congestive heart failure, hypertension, age >75 years, diabetes and previous stroke/transient ischemic attack (CHADS(2)) score was an independent predictor of AF recurrences. Moreover, among patients without recurrences at 2 years post-ablation, future recurrence rate during the subsequent follow-up was 64% in those with a CHADS(2) score of less than three, while it was only 3% in patients with a CHADS(2) score of zero. Patients with a higher CHADS(2) score have a different substrate, a more marked disease in the atrium and this may explain the higher rate of recurrence observed after AF ablation. Several more complex scores are available to separately identify the risk of different events in AF: stroke and embolic events, bleeding events, AF recurrences and progression to more sustained forms of AF. Whether it is a better strategy to use the simple CHADS(2) score to rapidly identify a global risk of all future events in AF more widely remains to be determined.

Download full-text PDF

Source
http://dx.doi.org/10.2217/fca.12.55DOI Listing

Publication Analysis

Top Keywords

chads2 score
28
atrial fibrillation
12
catheter ablation
12
events recurrences
8
recurrences patients
8
chads2
7
score
7
ablation
5
recurrences
5
events
5

Similar Publications

Patient Characteristics and Real-World Treatment of Very Elderly Patients with Nonvalvular Atrial Fibrillation in Japan: An Administrative Claims Database Study.

Cardiol Ther

December 2024

Internal Medicine Medical Affairs, Pfizer Japan Inc, 3-22-7 Yoyogi, Shibuya-Ku, Tokyo, 151-8589, Japan.

Introduction: Very elderly patients with nonvalvular atrial fibrillation (NVAF) are at high risk for both ischemic and hemorrhagic events. This study aimed to understand the characteristics and real-world treatment of very elderly patients with NVAF in Japan.

Methods: We conducted a retrospective analysis of electronic health records and claims data from acute care hospitals for very elderly patients with NVAF with medical records available on or after their 80th birthday.

View Article and Find Full Text PDF
Article Synopsis
  • - The study focused on how to manage antiplatelet agents in patients having cervical spinal surgery, looking specifically at risks like epidural hematoma and blood clots.
  • - Out of 153 patients, two groups were analyzed: one that didn't use antiplatelet agents before surgery and another that resumed them at specific times around the surgery, with no significant difference in serious complications observed.
  • - Results showed higher rates of pre-existing health conditions and stroke risk in the group that resumed antiplatelet medication, but they experienced less intraoperative blood loss and no complications related to bleeding or clotting.
View Article and Find Full Text PDF

Background: Disparities in atrial fibrillation ablation rates have been studied previously, with a focus on either patient characteristics or systems factors, rather than geographic factors. The impact of electrophysiology (EP) centre practice patterns on ablation rates has not been well studied.

Methods: This population-based cohort study used linked administrative datasets covering physician billing codes, hospitalizations, prescriptions, and census data.

View Article and Find Full Text PDF

Background: The Amulet IDE trial (AMPLATZER Amulet Left Atrial Appendage Occluder [LAAO] Investigational Device Exemption [IDE] Trial) evaluated the safety and effectiveness of the Amulet occluder (Abbott) in patients with nonvalvular atrial fibrillation. The Amulet IDE trial is the largest randomized LAAO trial, comparing the Amulet occluder with the Watchman 2.5 device (Boston Scientific).

View Article and Find Full Text PDF
Article Synopsis
  • In rural areas, atrial fibrillation (AF) management is primarily handled by local primary care providers, and there may be differing health outcomes for rural versus urban patients.
  • A study analyzed data from the IMPACT-AF trial, comparing a clinical decision support system to standard care for AF management among 1133 patients, with 54.1% living in rural locations.
  • Results showed rural patients had more referrals to general internists but fewer to cardiologists, and while there were no overall differences in emergency visits or hospitalizations, rural patients experienced higher rates of recurrent AF-related issues compared to urban patients.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!